The University of Illinois Cancer Center

What The University of Illinois Cancer Center does

The University of Illinois Cancer Center is an NCI-designated cancer center operating as a component of the University of Illinois Chicago (UIC), a public state university. Its stated mission is to eliminate cancer health inequities by elevating the voices of diverse communities as stakeholders in discovery, education, and care provision. The center conducts multi-disciplinary cancer research spanning basic science, translational science, clinical research, and population sciences, and delivers clinical care through the UI Health academic health system. It serves patients and survivors, researchers and clinicians, community members across Illinois (particularly underserved populations), and medical trainees.

The center's product and program portfolio includes the Data Hub for Communities (an interactive Illinois-specific cancer burden and risk factor visualization platform with downloadable charts, maps, and tables), the Illinois Breast and Cervical Cancer Program (IBCCP, offering free screenings and diagnostic services in partnership with the Illinois Department of Public Health), the Hope Leaders community-researcher partnership program, the ASSETS Series stakeholder engagement program, the U2D2 Drug Discovery Program (in partnership with UICentre for anti-cancer therapeutics development), the Data-Driven Policy and Planning Toolkit, community wellness fairs, the annual 5K Walk and Run, and recurring academic seminar and lecture series (Best Practice Hour, CRISS, Cancer Survivorship Lecture Series, Dr. Tapas Das Gupta Cancer Research Symposium). Technology infrastructure is limited to the data visualization platform; no APIs, SDKs, or mobile applications are offered.

Revenue is generated through a diversified, non-commercial mix: competitive federal research grants (NCI, NIH), pharmaceutical-sponsored research agreements (Boehringer Ingelheim, Genentech), foundation grants (American Cancer Society, Leukemia Research Foundation), clinical services delivered via UI Health, free screening programs funded through state public health partnerships, and philanthropy/donations. Pricing is non-commercial: most community-facing programs, including IBCCP screenings, are free of charge. Distribution is regional (Illinois), with services delivered directly through UI Health facilities, a network of FQHCs and community partner organizations, and virtual lecture/seminar channels.

Name

The University of Illinois Cancer Center

Legal name

University of Illinois Cancer Center

Website

https://cancer.uillinois.edu

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

The University of Illinois Cancer Center is an NCI-designated cancer center within the University of Illinois Chicago system that conducts multi-disciplinary cancer research, delivers clinical care through UI Health, and runs community health equity and free screening programs across Illinois for patients, researchers, and underserved communities.

Ownership category

akta.pro rank

Product category

Academic Cancer Research and Treatment

NAICS

Colleges, Universities, and Professional Schools (6113), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer) (HLAJANAG), Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Cancer research services
• Clinical trial programs
• Cancer health equity
• Oncology research training
• Community health programs

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Research Grants and Funding: The Cancer Center generates revenue through competitive grant funding from the National Cancer Institute (NCI), National Institutes of Health (NIH), foundations including American Cancer Society, Leukemia Research Foundation, and various pharmaceutical company-sponsored research agreements.
2. Healthcare Services: Clinical care services provided through UI Health academic health system, including cancer treatment, clinical trials, and patient navigation services.
3. Philanthropy and Donations: Donations and fundraising support through events like the annual 5K Walk and Run, with proceeds benefiting the Cancer Center to provide equal access to treatment.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

The University of Illinois Cancer Center is an NCI-designated academic cancer research institution that conducts basic, translational, population, and clinical cancer research; delivers cancer treatment and clinical trial services through UI Health; and runs community health programs focused on eliminating cancer health inequities across Illinois. It also provides research training, professional education, and operates an interactive data visualization platform (Data Hub for Communities) to support policy, outreach, and research decisions.

Product overview

The University of Illinois Cancer Center is an academic cancer research institution offering a portfolio of programs including the Data Hub for Communities (an interactive data visualization platform for Illinois cancer statistics), community health programs such as the Illinois Breast and Cervical Cancer Program (IBCCP), training programs like Hope Leaders, community engagement initiatives such as the ASSETS Series, and educational/scientific events including symposiums, lecture series, and seminars. The Cancer Center does not operate as a commercial technology product company but rather provides research, clinical, and community health services.

Differentiator

Problem solved

Functional benefit

Products and services

• Data Hub for Communities

Quantifiable outcome

• Three Cancer Center members received Chancellor's Translational Research Initiative (CTRI) Fund awards in 2026
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Boehringer IngelheimcoreStrategic or Co-development PartnerCollaboration with Cancer Center member Alexandra Naba, PhD on research to make immunotherapy more effective against pancreatic ductal adenocarcinoma (PDAC). This study could pave the way for new discoveries for a cancer with among the worst prognoses.
• Illinois Department of Public HealthcoreStrategic or Co-development PartnerPartner in the Illinois Breast and Cervical Cancer Program (IBCCP) offering FREE breast and cervical cancer screenings, diagnostic services, and treatment to eligible Illinois residents.
• UICentrecoreStrategic or Co-development PartnerPartnership with UIC's campus-wide drug discovery initiative for the U2D2 collaborative grant program directed at development of new anti-cancer therapeutics. Provides bioassay development, chemical library screening, hit counter-screening, and medicinal chemistry optimization.
• GenentechminorStrategic or Co-development PartnerSponsor of the 2025 ASSETS Series 'Structural Solutions to Clinical Research Excellence' - conversations with patients, survivors, communities, legislative champions, pharmaceutical industry leaders and healthcare professionals focused on strengthening collaborations to expand clinical trial access.
• Fenworth FinancialminorGTM or Marketing PartnerSponsor of the University of Illinois Cancer Center 5K Walk and Run event.
• UI Health Mile Square Health CentercoreStrategic or Co-development PartnerMile Square Health Center is a Federally Qualified Health Center (FQHC) affiliated with UI Health. Yamilé Molina, PhD serves as Associate Director for Community Engaged Research at Mile Square. Karriem Watson, DHSc is Chief Executive Officer of Mile Square Health Center.
• Sisters Working It OutcoreStrategic or Co-development PartnerCommunity organization founded by Monica Peek, MD, MPH, MS focused on addressing disparities in breast cancer outcomes. Partnered with Sandeep Kumar, PhD through Hope Leaders program.
• Gilda's Club ChicagocoreStrategic or Co-development PartnerFree support community for anyone affected by cancer. Partnered with Paul Grippo, PhD through Hope Leaders program to bring researchers to community events and share cancer research in accessible ways.
• Brighton Park Neighborhood CouncilminorStrategic or Co-development PartnerCommunity organization partnered with the lab of Constance Jeffery, PhD through the Hope Leaders program for community-based research collaboration.
• Peer Plus Education and Training AdvocatesminorStrategic or Co-development PartnerCommunity partner paired with Ameen Salahudeen, MD, PhD through Hope Leaders program.
• American Cancer SocietycoreStrategic or Co-development PartnerPartner through Cancer Center-American Cancer Society Institutional Research Grant (ACS IRG) Bridge Pilots program providing seed money for newly independent investigators. Active advocacy partnership for cancer prevention and screening program funding.
• Big Ten Cancer Research ConsortiumcoreStrategic or Co-development PartnerThe Cancer Center is hosting the 2026 Big Ten CRC Summit at Big Ten Conference Headquarters in Rosemont, IL. Active member of this collaborative research network.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• University of Chicago Medicine Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center on Chicago's South Side, embedded in a major academic medical center. Direct peer competing for translational research funding, oncology referrals, and trainees within the same metro.
• Roswell Park Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with strong community outreach and clinical trials emphasis, operating in a similar mid-size city context. Comparable in scope of research-to-community programming.
• Sylvester Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at the University of Miami, part of a public-university academic health system. Comparable in structure, clinical-trial scale, and cancer disparities focus serving diverse populations.
• UNC Lineberger Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at a public research university with comparable scope of basic, translational, clinical, and population sciences research. Similar scale of faculty, training programs, and community engagement.
• University of Michigan Rogel Cancer Center: NCI-designated Comprehensive Cancer Center at a major Big Ten public research university and Big Ten CRC member. Closely comparable in academic scale, NCI designation, translational pipeline, and Big Ten collaborative opportunities.
• Northwestern University Robert H. Lurie Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center located in downtown Chicago, part of Northwestern Medicine. Direct geographic and mission competitor for patients, clinical trials, faculty recruitment, and pharma-sponsored research in the same metropolitan market.
• Rutgers Cancer Institute of New Jersey: New Jersey's only NCI-designated Comprehensive Cancer Center, embedded in a public state university system. Structurally analogous as a state-university NCI center with strong community outreach and clinical trials emphasis.
• Indiana University Melvin and Bren Simon Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at a Big Ten peer university and fellow Big Ten CRC member. Comparable structure (public university, NCI designation, clinical-trial-driven research) and direct collaborator on multi-site Big Ten trials.
• O'Neal Comprehensive Cancer Center at UAB: NCI-designated Comprehensive Cancer Center at a public research university in the Deep South with strong community outreach to underserved populations. Comparable in mission, public-university structure, and health-equity emphasis.
• University of Wisconsin Carbone Cancer Center: NCI-designated Comprehensive Cancer Center at another Big Ten public research university and Big Ten CRC member. Highly comparable in scale, structure, and translational research orientation, with overlapping faculty networks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCwK46TUWG2toAQ0FtaFcpHw
• Facebookfacebook.com/UICancerCenter
• LinkedInlinkedin.com/company/the-university-of-illinois-cancer-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles25 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The University of Illinois Cancer Center